Scientific Program

Download Preliminary Scientific Program (PDF version)

Web version latest update: 2020-09-25 | PDF version latest update: 2020-09-25

13:00 | Registration

14:00 | Opening ceremony

14:15 | Marta Boccazzi (Starting Grant 2019 Winner), The immune-inflammatory response of oligodendrocytes in a murine model of preterm white matter injury: the role of TLR3 activation.

14:30 | Lecture • LUCAS SCHIRMER, Multilineage vulnerability and reactivity in chronic neuroinflammation.


15:00 – 15:15 – 15:30 | Accepted oral presentation (3)

15:45 | BraYn Educational Symposium 1

Andrea Paolillo (Merck Serono), Merck heritage and commitment in the new MS era: past, present and future.

16:05 | BraYn Educational Symposium 2

Francesca Sangalli (Sanofi), Innovation through patient needs: Bruton Tyrosine Kinase Inhibitor (BTKi) development journey.

16:25 | Coffee Break mini 1

17:00 – 17:15 – 17:30 | Accepted oral presentation (3)

18:00 | BraYn Educational Workshop 1

(Beckman Coulter), Technological enhancement in Flow cytometry.

18:15 | Poster session 1 (2h)

20:00 | Closing Remarks


9:30 – 9:45 – 10:00 | Accepted oral presentations  (3)

10:15 | BraYn Educational Symposium 2

Chloè Dominici (Miltenyi Biotec), 3D analysis of neural network remodeling in pancreatic cancer.

10:35 | Coffee Break mini 2

11:00 | BraYn Educational Symposium 3

Daniela Carnevale (Becton Dickinson), Neural regulation of immunity in cardiovascular diseases.

11:20 – 11:35 – 11:50 | Accepted oral presentations (3)

12:30 | Lunch box with BraYn Open Lab (1h30)

14:00 | Lecture • ALESSANDRA PIERANI, Life and death of transient neurons in the maturation of functional and dysfunctional cortical circuits.


14:30 – 14:45 | Accepted oral presentations (2)

15:00 | BraYn Educational Symposium 4

Claudia Maria Radu (Beckman Coulter) Extracellular vesicles as emerging biomarkers for diagnosis and therapy.

15:20 – 15:35 | Accepted oral presentations (2)

15:45 | Coffee Break 3 with Poster Session 2 + “Lost in the protocol” session  (2h)

17:45 | Lecture • MANUEL VALIENTE, Strategies to challenge an unmet clinical need.


18:15 – 18:30 – 18:45 – 19:00 | Accepted oral presentations (4)

20:30 | BraYn Social Dinner


9:00 | Lecture • EMILIANO BIASINI, Targeting Protein Folding Intermediates in Neurodegenerative Diseases.

9:30 – 9:45 – 10:00 | Accepted oral presentations  (3)

10:30 | BraYn Educational Symposium 5

Amalia Cecilia Bruni (Biogen), Alzheimer: from gene’s discovery to the first therapeutic chance.

10:50 | Coffee Break mini 4 with Poster session 3 (1h)

11:50 | BraYn Educational Symposium 6

Mara Colzani (PerkinElmer), A journey into neuroscience: how can PerkinElmer support your research?

12:10 – 12:25 – 12:40 | Accepted oral presentations (3)

13:00 | Lecture • CESARE MONTECUCCO, Neurodegeneration and Neuroregeneration in the Peripheral Nervous System.

13:30 | Closing Remarks • BraYn Awards (Best Oral and Poster Presentation and BraYn Starting Grant)

Invited Speakers

Dipartimento di Biologia Cellulare, Computazionale e Integrata – CIBIO Università di Trento (Italy)

Brain Metastasis Group, CNIO – Centro Nacional de Investigaciones Oncológicas, Madrid (Spain)

 CNR Neuroscience Institute Padova (Italy)


Institute of Psychiatry and Neuroscience of Paris, Université Paris Descartes (France)


University of Heidelberg (Germany)

Trinity College, Dublin (Ireland)

I obtained a master’s degree in Molecular Biology and a Phd in Cellular and Molecular Pathology and Biology. In 10 years of research activity at the University of Verona (Italy) I investigated the molecular mechanisms controlling leukocyte trafficking in the central nervous system during neuroinflammatory diseases such as experimental autoimmune encephalomyelitis, epilepsy and Alzheimer disease.
I also studied the immuno-modulatory properties of adipose-derived mesenchymal stem cells (ASCs) and ASC-derived nanovescicles in neurological diseases. I recently moved to the Trinity College Dublin (Ireland) to develop a research project investigating the metabolic regulation of adaptive immune responses.

San Raffaele Scientific Institute, Milan (Italy)

Barbara Bettegazzi, 35 years old, married. I am currently working as a post doctoral researcher in Professor Grohovaz’s laboratory at San Raffaele Scientific Institute in Milan, Italy, where I obtained my PhD in Molecular Medicine in 2012. During my PhD I worked mainly on Alzheimer’s disease pathogenesis, studying the mechanisms regulating the expression and activity of BACE1, the main β-secretase of the brain. During my PhD I spent two years in Munich, in the laboratory of C. Haass, a pioneer in the Alzheimer’s disease field and our collaboration is still ongoing. More recently I shifted my research focus on studying whether alterations in the control of protein synthesis could contribute to the development of complex diseases, like Alzheimer’s disease and epilepsy.

Neuroscience Institute «Cavalieri Ottolenghi», Dept. of Neuroscience, University of Turin (Italy)

Enrica Boda, 36 years old, married. Enrica is a neurobiologist sand has just got a position as Assistant Professor in tenure track (RTD-B) in Human Anatomy at the University of Turin. She’s now working in the research group of  “Physiopathology of neural stem cells” at the Neuroscience Institute of the Cavalieri Ottolenghi Foundation (NICO, Orbassano, Turin). Her studies are focused on the molecular mechanisms regulating the self-renewal and differentiation of neural progenitor cells (oligodendrocyte progenitors andneural stem cells) in health and disease, with a special focus on de-/dis-myelinating diseases, such as Multiple Sclerosis and neurodevelopmental disorders.

University of Catania (Italy)

I’m Giovanna Calabrese, I have a PhD in Medical Embryology, Pathology and Experimental Hematology. Currently, I’m a post-doc at the University of Catania, Dept. of Biomedical and Biotechnological Sciences. My main research topic is regenerative medicine and tissue engineering applied to both neural and osteo/chondral regeneration. Specifically, I’m studying the repairing capabilities of the combination between mesenchymal stem cells and 3D biomimetic materials, both in vitroand in animal models.

Scroll to Top